STCC-NCCS-NUH_Roche signed a MOU_3.jpg

New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore

Our Joint Platforms

We are committed to working together in new and better ways towards translating research into applications that optimise clinical outcomes.

The joint platforms  enable  collaboration  between basic, clinical and translational researchers  to  explore novel  approaches,  push  promising  lines  of  research and translation, and seed ideas for larger competitive translational grants.

Singapore Translational Cancer Consortium's Clinical Trials & Investigational Medicine Units Platform
Cancer Clinical Trials & Investigational Medicine Units (IMUs)
Cancer Databases & Tissue Banks
STCC's Joint Platforms
Singapore Translational Cancer Consortium Research-based molecular diagnostic platform Co-lead Dr Anand Jeyasekharan
Research-based
Molecular Diagnostics 
Business Intelligence & Development Unit
STCC's Joint Platforms

Our Leadership Team

Latest News

Our Collaborators

We partner with key stakeholders and institutions to implement joint platforms that are functionally integrated and operational in support of the nation's long term goals to achieve value-based healthcare and economic outcomes through deeper industry collaborations, patents and invention disclosures, start-ups and clinically validated diagnostics. 

Supported by:
MOH.jpeg
NRF.jpeg
NMRC.jpeg
Our Partners:
astar-og-1200x630.jpg
NUHS Logo CMYK.png
BMS IPO.png
NUH Logo_Full Colour (With Endorsement L
NCCS.jpeg
NHG-Logo_Enhanced_jpg.jpg
NCIS Logo_Full Colour (With Endorsement
CSI_Logo.png